Fisher Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-58
Closed -$2.67K 983
2023
Q3
$2.67K Buy
+58
New +$3.16K ﹤0.01% 1132
2018
Q3
Sell
-130,468
Closed -$1.99M 816
2018
Q2
$1.99M Sell
130,468
-76,133
-37% -$1.33M ﹤0.01% 533
2018
Q1
$3.87M Sell
206,601
-22,676
-10% -$426K 0.01% 459
2017
Q4
$4.41M Buy
229,277
+17,094
+8% +$319K 0.01% 438
2017
Q3
$3.79M Buy
212,183
+16,636
+9% +$274K 0.01% 431
2017
Q2
$3.49M Buy
195,547
+44,492
+29% +$706K 0.01% 416
2017
Q1
$2.19M Buy
151,055
+51,731
+52% +$813K ﹤0.01% 429
2016
Q4
$1.83M Sell
99,324
-98,334
-50% -$1.91M ﹤0.01% 431
2016
Q3
$3.75M Sell
197,658
-52,673
-21% -$956K 0.01% 379
2016
Q2
$4.24M Sell
250,331
-26,141
-9% -$369K 0.01% 366
2016
Q1
$3.52M Hold
276,472
0.01% 389
2015
Q4
$3.93M Buy
276,472
+44,610
+19% +$589K 0.01% 372
2015
Q3
$2.71M Buy
+231,862
New +$3.48M 0.01% 411

Other funds holding AMPH

Fisher Asset Management's AMPH Position: Q4 2023 in Review

Fisher Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 58 shares — an estimated $2.67K sold.

Fisher Asset Management first reported a position in AMPH in Q3 2015 and held it in 13 quarters. The position peaked at $4.41M in Q4 2017. 277 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • Fisher Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Fisher Asset Management sold 58 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $2.67K.
  • Fisher Asset Management first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 13 quarters.
  • Fisher Asset Management's Amphastar Pharmaceuticals position peaked at $4.41M in Q4 2017.
  • 277 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.